Detalhe da pesquisa
1.
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer.
Cell
; 158(3): 579-92, 2014 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25083869
2.
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer.
Cell
; 165(6): 1546-1547, 2016 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27259155
3.
Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma.
Gastroenterology
; 166(5): 886-901.e7, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096955
4.
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.
Gut
; 73(3): 496-508, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758326
5.
Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma.
Hepatology
; 78(6): 1742-1754, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789652
6.
Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis.
Hepatology
; 77(6): 1929-1942, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921500
7.
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre.
Br J Cancer
; 128(6): 1134-1147, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572733
8.
ß-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma.
Gastroenterology
; 163(2): 481-494, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489428
9.
Therapeutic efficacy of FASN inhibition in preclinical models of HCC.
Hepatology
; 76(4): 951-966, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076948
10.
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids.
Hepatology
; 76(6): 1617-1633, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030285
11.
Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis.
BMC Cancer
; 23(1): 1086, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946160
12.
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.
Int J Mol Sci
; 24(3)2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768380
13.
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer.
Gut
; 71(8): 1613-1628, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34509979
14.
Role of Lipogenesis Rewiring in Hepatocellular Carcinoma.
Semin Liver Dis
; 42(1): 77-86, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34311471
15.
TAZ is indispensable for c-MYC-induced hepatocarcinogenesis.
J Hepatol
; 76(1): 123-134, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464659
16.
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
J Hepatol
; 77(1): 177-190, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35217064
17.
Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice.
Am J Pathol
; 191(5): 930-946, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545120
18.
YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice.
Am J Pathol
; 191(9): 1651-1667, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129844
19.
Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies.
Hepatology
; 73 Suppl 1: 49-61, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32394479
20.
Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans.
Hepatology
; 74(1): 248-263, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368437